(1S,2S)-2-(2-{[3-(1H-Benzimidazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-2-naphthalenyl methoxyacetate(CAS: 116644-53-2)

This compound is subject to the REACH regulations in the European Union, GHS classification for hazardous chemicals, and FDA regulations for pharmaceuticals. EPA guidelines also apply for environmental protection. Specific handling, storage, and disposal methods must be followed according to the material safety data sheet (MSDS).

Alternative reagents such as naphthalenyl methoxyacetic acid and benzimidazole derivatives can be used as starting materials. Isomers like (1R,2R)-isomers and analogs with different functional groups can also be explored as alternatives in the synthesis process.

Research trends indicate a focus on developing novel pharmaceuticals and agrochemicals due to its structural complexity and potential biological activity. Market trends show increasing demand in the pharmaceutical industry for compounds with antifungal and antibacterial properties. Additionally, there is growing interest in the application of such compounds in cancer therapy and pesticide development.

Waste containing this compound should be collected in appropriate containers and disposed of through incineration or professional hazardous waste disposal services. Precautions include proper labeling, containment to prevent spillage, and adherence to local and national regulations for hazardous waste management. Environmental protection measures are crucial to minimize ecological impact.